INSM: Insmed Incorporated Stock

by  •  • Comments Off on INSM: Insmed Incorporated Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3,684.17
Enterprise Value ($M) 4,512.14
Book Value ($M) -331.92
Book Value / Share -2.23
Price / Book -11.10
NCAV ($M) -732.70
NCAV / Share -4.93
Price / NCAV -5.03

Profitability (mra)
Return on Invested Capital (ROIC) -0.73
Return on Assets (ROA) -0.49
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 3.75
Current Ratio 4.12

Balance Sheet (mrq) ($M)
Current Assets 929.06
Assets 1,329.84
Liabilities 1,661.76
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 305.21
Operating Income -680.93
Net Income -749.57
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -536.25
Cash from Investing -223.60
Cash from Financing 168.44

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-16 13G/A T. Rowe Price Investment Management, Inc. 4.10 0.00
02-14 13G/A Price T Rowe Associates Inc /md/ 7.50 8.03
02-13 13G/A Vanguard Group Inc 9.87 -1.98
01-25 13G/A BlackRock Inc. 8.00 3.41
01-22 13G/A State Street Corp 4.15 -13.89

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PUR
2023-10-26 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-19 578,004 2,568,326 22.51
2024-04-18 388,624 1,808,060 21.49
2024-04-17 208,425 889,304 23.44
2024-04-16 913,863 501,201 182.33
2024-04-15 475,172 658,350 72.18

(click for more detail)

Similar Companies
IMVT – Immunovant, Inc. INDV – Indivior PLC
INNV – InnovAge Holding Corp. INVA – Innoviva, Inc.
INZY – Inozyme Pharma, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Insmed